Table 1. Patient’s characteristics.
| Patient | Age | Sex | Metastasis | Interval between Surgeries (days) | Histology | pT | pN | DFS (months) | OS (months) | Current status |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 54 | M | Synchronic | 19 | NSCLC | 1c | 0 | 38 | 51.4 | Deceased |
| 2 | 70 | M | Synchronic | 20 | LCNEC | 4 | 0 | 9.01 | 9.01 | Deceased |
| 3 | 80 | M | Synchronic | 35 | LCNEC | 2a | 0 | 20.6 | 20.6 | Deceased |
| 4 | 75 | M | Synchronic | 20 | NSCLC | 2b | 0 | 30.4 | 36 | Alive |
| 5 | 60 | M | Synchronic | 13 | NSCLC | 1b | 0 | 60.7 | 60.7 | Alive |
| 6 | 78 | M | Synchronic | 35 | NSCLC | 2a | 0 | 44.7 | 44.7 | Alive |
| 7 | 78 | F | Synchronic | 34 | NSCLC | 3 | 1 | 10.1 | 19.1 | Deceased |
| 8 | 65 | M | Synchronic | 62 | NSCLC | 3 | 0 | 11.9 | 22.9 | Deceased |
| 9 | 50 | F | Metachronic | 518 | NSCLC | 1c | 0 | 51.4 | 51.4 | Alive |
| 10 | 69 | M | Synchronic | 26 | NSCLC | 3 | 2 | 2 | 6 | Deceased |
| 11 | 57 | M | Metachronic | 540 | NSCLC | 3 | 0 | 31.9 | 31.9 | Alive |
DFS: disease-free survival; OS: overall survival; NSCLC: non-small cell lung cancer; LCNEC: large cell neuroendocrine carcinoma